Clinical Trial Update: Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial [Phase 3]

View source ↗

Summary

NAMinG is a phase III, randomized, placebo-controlled trial evaluating nicotinamide for open-angle glaucoma, with recruitment ongoing across multiple centers. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: University College, London | Conditions: Glaucoma, Open-Angle | Phase 3 | Status: RECRUITING